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ABSTRACT
An aromatic amine, o-anisidine (2-methoxyaniline) and its oxidative counterpart, 2-nitroanisole (2-methoxynitrobenzene), are the 
industrial and environmental pollutants causing tumors of the urinary bladder in rats and mice. Both carcinogens are activated to the 
same proximate carcinogenic metabolite, N-(2-methoxyphenyl)hydroxylamine, which spontaneously decomposes to nitrenium and/
or carbenium ions responsible for formation of deoxyguanosine adducts in DNA in vitro and in vivo. In other words, generation of  N-(2-
methoxyphenyl)hydroxylamine is responsible for the genotoxic mechanisms of the o-anisidine and 2-nitroanisole carcinogenicity. 
Analogous enzymes of human and rat livers are capable of activating these carcinogens. Namely, human and rat cytochorme P450 2E1 
is the major enzyme oxidizing o-anisidine to N-(2-methoxyphenyl)hydroxylamine, while xanthine oxidase of both species reduces 
2-nitroanisole to this metabolite. Likewise, O-demethylation of 2-nitroanisole, which is the detoxication pathway of its metabolism, 
is also catalyzed by the same human and rat enzyme, cytochorme P450 2E1. The results demonstrate that the rat is a suitable animal 
model mimicking the fate of both carcinogens in humans and suggest that both compounds are potential carcinogens also for 
humans.
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metabolic pathways and the persistence of residues of 
these compounds and/or their metabolites in organisms 
have been examined (NTP, 1978; 1993; IARC, 1989; 1982; 
Purohit and Basu, 2000). However, the knowledge of the fate 
of several aromatic nitro compounds or aromatic amines 
and their physiological effects in humans is still scarce 
(Purohit and Basu, 2000). This also the case of compounds 
such as 2-methoxyaniline (o-anisidine) and 2-nitroanisole 
(2-methoxynitrobenzene) (Figures 1 and 2). 
Toxicity, carcinogenicity and metabolism 
of o-anisidine and 2-nitroanisole
o-Anisidine and 2-nitroanisole are potent carcinogens, 
causing tumors of the urinary bladder in both genders of 
rats and mice (NTP, 1978; IARC, 1982; NTP, 1993). The 
International Agency for Research on Cancer (IARC) has 
classified o-anisidine as a group 2B carcinogens (IARC, 
1982), which is possibly carcinogenic to humans. Besides 
Introduction
Aromatic nitro-compounds and amines are potent toxic or 
carcinogenic compounds, presenting a considerable danger 
to the human population (NTP, 1978; 1993; Garner et al., 
1984; IARC, 1982; 1989). They are widely distributed envi-
ronmental pollutants found in workplaces (e.g. in chemical 
industry), in emissions from diesel and gasoline engines 
and on the surface of ambient air particulate matter (IARC, 
1989; 1982; NTP, 1978; 1993), where they add to local and 
regional pollution (car exhausts, technological spills). The 
toxicity and carcinogenicity of these compounds, their 
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its carcinogenicity it exhibits other toxic effects, including 
hematological changes, anemia and nephrotoxicity (NTP, 
1978; IARC, 1982). o-Anisidine is used as an intermediate 
in the manufacturing of a number of azo and naphthol 
pigments and dyes, which are used for printing (90%) and 
for paper (3%) and textile (7%) dyeing (NTP, 1978; Garner 
et al., 1984). Such a wide use of this aromatic amine could 
result in occupational exposure. Furthermore, it may be 
released from textiles and leather goods colored with these 
azo dyes and a large part of the population may be exposed. 
This carcinogen is also a constituent of cigarette smoke 
(IARC, 1982; Stabbert et al., 2003). This strongly suggests 
that o-anisidine ranks not only among occupational pollut-
ants produced in the manufacturing of chemicals, but also 
among environmental pollutants; it can be assumed that 
human exposure is widespread. Indeed, o-anisidine was 
found in human urine samples in the general population, 
in concentrations of 0.22 μg/l (median) (Weiss and Angerer, 
2003). In addition, hemoglobin adducts of o-anisidine were 
detected in blood samples of persons living in urban or rural 
areas of Germany (Falter et al., 1994; Branner et al., 1998; 
Richter et al., 2001). The adducts as well as o-anisidine in 
urine might originate not only from the sources mentioned 
above, but also from a possible o-anisidine precursor, 
2-methoxynitrobenzene (2-nitroanisole). This chemical was 
released into the environment in the course of an accident 
in a German chemical plant, causing subsequently local 
and regional contamination (Falter et al., 1994; Hauthal, 
1993; Traupe et al., 1997). 2-Nitroanisole exhibits strong 
carcinogenic activity, causing neoplastic transformation in 
the urinary bladder, and to a lesser extent, in the spleen, 
liver and kidneys in rodents (NTP 1993). It is also a toxic 
compound, causing anemia. The anemia is characterized by 
increased levels of methemoglobin and accelerated destruc-
tion of erythrocytes (NTP 1993). 
Recently, we have found that o-anisidine is oxidatively 
activated by peroxidase and cytochrome P450 (CYP) to 
species binding to DNA in vitro (Stiborová et al., 2001; 
2002; 2005; Rýdlová et al., 2005; Naiman et al., 2008b). We 
also demonstrated that o-anisidine forms DNA adducts in 
vivo. The same adducts as found in DNA incubated with 
o-anisidine and human microsomes in vitro were detected 
in urinary bladder, the target organ, and to a lesser extent, 
in liver, kidney and spleen of rats treated with o-anisidine 
(Stiborová  et al., 2005). The o-anisidine-derived DNA 
adducts were identified as deoxyguanosine adducts formed 
from a metabolite of o-anisidine, N-(2-methoxyphenyl)
hydroxylamine, which is generated by oxidation of 
o-anisidine with human, rabbit and rat hepatic microsomes 
(Stiborová et al., 2005; Rýdlová et al., 2005; Naiman et 
al., 2008b). The same deoxyguanosine adducts were also 
detected in DNA of the urinary bladder, kidney, liver 
and spleen of rats treated with 2-nitroanisole (Stiborová 
et al., 2004), an oxidized counterpart of o-anisidine, 
and in DNA incubated with 2-nitroanisole in vitro with 
human and rat hepatic cytosolic enzymes and xanthine 
oxidase (Stiborová et al., 1998; 2004). These enzymatic 
systems were found to produce N-(2-methoxyphenyl)
hydroxylamine after 2-nitroanisole reduction (Mikšanová 
et al., 2004a) (Figure 2). The data indicate that formation 
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Figure 1. Pathways of o-anisidine metabolism by the cytochrome P450 system showing the characterized metabolites and those proposed to 
form DNA adducts. The compounds shown in brackets were not detected under the experimental conditions.26
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of  N-(2-methoxyphenyl)hydroxylamine, the reactive 
metabolite of both carcinogens, is critical for generation 
of DNA lesions in target organs. Therefore, it is clear that 
N-(2-methoxyphenyl)hydroxylamine formation and its 
further conversion, as well as the enzymes participating in 
such processes, play a key role in carcinogenic effects of 
both carcinogens. Oxidation of 2-nitroanisole by rat, rabbit 
and human hepatic microsomal cytochrome P450 enzymes 
leads to its detoxication. O-Demethylation of 2-nitroanisole 
to 2-nitrophenol and its hydroxylated products, 2,5-dihy-
droxynitrobenzene and 2,6-dihydroxynitrobenzene, did 
not form any adducts with DNA (Mikšanová et al., 2004b; 
Dračínská et al., 2006). 2-Nitroanisole metabolite 2-nitro-
phenol is the major metabolite generated by rabbit and rat 
microsomal enzymes, but 2,5-dihydroxynitrobenzene is 
the predominant product formed in human microsomal 
cytochromes P450 (Mikšanová et al., 2004b; Dračínská 
et al., 2006; Svobodová et al., 2008) (Figure 2). Therefore, 
hepatic microsomal P450 enzymes participate in detoxica-
tion of this environmental carcinogen.
Recently, we have found that o-anisidine is oxidized by 
human, rat and rabbit hepatic microsomes containing cyto-
chromes P450 not only to N-(2-methoxyphenyl)hydroxyl-
amine, but that this compound is a subject of complex redox 
cycling reactions, forming also o-aminophenol, 2-nitro-
soanisole and one additional metabolite, the exact structure 
of which has not been identified as yet (Stiborová et al., 
2005; Naiman et al., 2008a; 2008b). N-(2-methoxyphenyl)
hydroxylamine might also be a subject of complex reactions, 
and its fate is dependent on the environment, in which it 
occurs. It can be further metabolized to o-aminophenol, 
o-nitrosoanisole and parental o-anisidine (Naiman et al., 
2008a; 2008b), or when nucleophiles such as DNA or pro-
teins are present in the cell, form the adducts (Stiborová et 
al., 2005) (Figure 1). 
Conclusion
The results of our former (Stiborová et al., 1998; 2004; 2005) 
and the present studies (unpublished data) indicate that three 
DNA adducts found in vitro and in vivo are formed from 
N-(2-methoxyphenyl)hydroxylamine and deoxyguanosine 
in DNA. The physico-chemical properties of these adducts 
suggest that they are polar compounds, in which only one 
benzene ring of the original o-anisidine and/or 2-nitroan-
isole molecules is bound to this deoxynucleoside. Recently, 
their structures were suggested to be the structures of 
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Figure 2. Pathways of 2-nitroanisole metabolism showing the characterized metabolites and those proposed to form DNA adducts. 
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adducts, in which nitrenium and/or carbenium ions formed 
from N-(2-methoxyphenyl)hydroxylamine are bound to C8, 
O6, and/or N2 in the guanine residue (Stiborová et al., 2005). 
The aim of our current and future research in our labora-
tory is to confirm this suggestion. Procedures to prepare 
the adducts generated by reactions N-(2-methoxyphenyl)
hydroxylamine with deoxygunaosine and HPLC methods 
to separate adducts from other components of the reaction 
mixtures were developed in our laboratory. They will lead 
to obtain adducts in amounts sufficient for their structural 
characterization by mass- and NMR spectrometry. 
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